| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |